Tirzepatide requires milligram doses up to 6x higher than semaglutide, which is why compounded vials come in higher concentrations to keep injection volumes small.
Semaglutide maintenance doses typically range from 0.5 mg to 2.4 mg per week. Tirzepatide maintenance doses range from 5 mg to 15 mg per week. That means the highest tirzepatide dose (15 mg) is more than six times the highest standard semaglutide dose (2.4 mg).
This difference is not a matter of potency or effectiveness -- it reflects the pharmacology of each molecule. Tirzepatide simply requires more milligrams of the active compound to achieve its therapeutic effect. Both medications are highly effective for weight loss and metabolic improvement at their respective dose ranges. The starting dose for tirzepatide (2.5 mg) is already higher than the maximum semaglutide dose for diabetes (2 mg), which illustrates just how different the dosing scales are.
When you inject medication from a vial using a U-100 insulin syringe, the volume you draw depends on two factors: your milligram dose and the vial concentration. The formula is:
volume in mL = dose in mg / concentration in mg/mL
If you tried to draw 15 mg of tirzepatide from a 5 mg/mL vial (a concentration common for semaglutide), you would need 3 mL of liquid. That is far too much for a single subcutaneous injection -- a standard insulin syringe only holds 1 mL, and even that volume can be uncomfortable.
By concentrating tirzepatide at 20 mg/mL or 30 mg/mL, the same 15 mg dose requires only 0.75 mL or 0.5 mL respectively. These are practical, comfortable injection volumes that fit in a standard syringe.
Compounded semaglutide vials are typically available at:
1 mg/mL, 2 mg/mL, 2.5 mg/mL, and 5 mg/mL
Compounded tirzepatide vials are typically available at:
5 mg/mL, 10 mg/mL, 20 mg/mL, and 30 mg/mL
Notice the range difference. The highest standard semaglutide concentration (5 mg/mL) is the lowest standard tirzepatide concentration. This direct relationship between dose range and concentration ensures that patients on either medication draw roughly similar injection volumes -- typically between 10 and 75 units (0.1 to 0.75 mL) depending on the dose.
Let us compare two common scenarios side by side:
Semaglutide 1.0 mg from a 5 mg/mL vial: units = (1.0 / 5) x 100 = 20 units
Tirzepatide 10 mg from a 20 mg/mL vial: units = (10 / 20) x 100 = 50 units
Despite the tirzepatide dose being 10x higher in milligrams, the syringe draw is only 2.5x larger in units. This is entirely because the tirzepatide vial is 4x more concentrated. Higher concentrations compress the dose into a smaller volume, making the injection practical.
This is also why you should never assume the unit count is interchangeable between medications. Drawing 20 units from a semaglutide vial and 20 units from a tirzepatide vial would deliver very different milligram doses.
Always verify the medication name and concentration on your vial label before using any formula or calculator. If your provider switches you from one medication to the other, or if your pharmacy changes the vial concentration at refill time, the number of units you draw will change even if the milligram dose stays the same. When in doubt, contact your prescribing provider or pharmacist to confirm the correct unit count for your specific vial.
There's an easier way
We handle everything — the prescription, the right dose, and shipping straight to your door. No math, no hassle.
Get Started2-min quiz · Free consultation · No commitment
Take our 2-minute quiz to see if you qualify for GLP-1 treatment.
Start QuizFree consultation. No commitment.